Related Experiment Video
Updated: Mar 30, 2026

Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats
Published on: April 21, 2017
Risk of Recurrent Arterial Ischemic Stroke in Childhood: A Prospective International Study
Heather J Fullerton1, Max Wintermark2, Nancy K Hills2
1From the Departments of Neurology (H.J.F., N.K.H., A.J.B.), Pediatrics (H.J.F.), Biostatistics and Epidemiology (N.K.H.), and Radiology (A.J.B), University of California, San Francisco; Department of Radiology, Stanford University, Palo Alto, CA (M.W.); Departments of Pediatrics and Neurology and Neurotherapeutics, UT Southwestern Medical Center, Dallas, TX (M.M.D.); Departments of Pediatrics and Neurosciences, University of the Philippines-Philippine General Hospital, Manila, Philippines (M.T.); Section of Neurology, Children's Hospital, University of Manitoba, Winnipeg, Manitoba, Canada (M.F.R.); Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY (M.S.V.E.); Department of Epidemiology, Mailman School of Public Health, New York, NY (M.S.V.E.); and Department of Neurology, Hospital for Sick Children, Toronto, Ontario, Canada (G.A.d.V.). heather.fullerton@ucsf.edu.
Insights
Children with arterial ischemic stroke (AIS) face a significant risk of recurrence, with 1-year rates reaching 12%. Arteriopathy is the primary predictor, highlighting the need for targeted therapies beyond antithrombotic agents.
Area of Science:
- Pediatric Neurology
- Vascular Neurology
- Pediatric Stroke Research
Background:
- Historical 5-year recurrence rates for pediatric arterial ischemic stroke (AIS) approached 20% in the 1990s-2000s.
- Increased use of antithrombotic agents for secondary stroke prevention in children has occurred since then.
Purpose of the Study:
- To determine current rates of recurrent AIS in children.
- To identify predictors of recurrent stroke in the current era of increased antithrombotic use.
Main Methods:
- Prospective enrollment of 355 children with AIS in the Vascular Effects of Infection in Pediatric Stroke (VIPS) study (2009-2014).
- Central review of index and recurrent strokes, including cause classification (arteriopathies).
- Prospective follow-up for recurrent stroke events.
Main Results:
- The 1-year cumulative stroke recurrence rate was 12% (95% CI, 8.5%-15%).
- Arteriopathy was the sole predictor of recurrence, increasing risk 5-fold (HR, 5.0; 95% CI, 1.8-14).
- Specific arteriopathies like moyamoya showed high 1-year recurrence rates (32%).
Conclusions:
- Children with AIS, especially those with arteriopathy, remain at high risk for recurrence despite antithrombotic therapy.
- Novel therapies targeting the underlying arteriopathies are necessary for effective secondary prevention.
Background And Purpose:
Published cohorts of children with arterial ischemic stroke (AIS) in the 1990s to early 2000s reported 5-year cumulative recurrence rates approaching 20%. Since then, utilization of antithrombotic agents for secondary stroke prevention in children has increased. We sought to determine rates and predictors of recurrent stroke in the current era.
Methods:
The Vascular Effects of Infection in Pediatric Stroke (VIPS) study enrolled 355 children with AIS at 37 international centers from 2009 to 2014 and followed them prospectively for recurrent stroke. Index and recurrent strokes underwent central review and confirmation, as well as central classification of causes of stroke, including arteriopathies. Other predictors were measured via parental interview or chart review.
Results:
Of the 355 children, 354 survived their acute index stroke, and 308 (87%) were treated with an antithrombotic medication. During a median follow-up of 2.0 years (interquartile range, 1.0-3.0), 40 children had a recurrent AIS, and none had a hemorrhagic stroke. The cumulative stroke recurrence rate was 6.8% (95% confidence interval, 4.6%-10%) at 1 month and 12% (8.5%-15%) at 1 year. The sole predictor of recurrence was the presence of an arteriopathy, which increased the risk of recurrence 5-fold when compared with an idiopathic AIS (hazard ratio, 5.0; 95% confidence interval, 1.8-14). The 1-year recurrence rate was 32% (95% confidence interval, 18%-51%) for moyamoya, 25% (12%-48%) for transient cerebral arteriopathy, and 19% (8.5%-40%) for arterial dissection.
Conclusions:
Children with AIS, particularly those with arteriopathy, remain at high risk for recurrent AIS despite increased utilization of antithrombotic agents. Therapies directed at the arteriopathies themselves are needed.
More Related Videos
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Coronary Artery Disease I: Introduction
Peripheral Artery Disease I: Introduction

